Zelira in the news
Zelira Therapeutics’ insomnia treatment gets TGA tick
Shares in Perth-based Zelira Therapeutics have surged after the medicinal cannabis company announced its insomnia treatment can now be prescribed in Australia.
The company’s stock was up 11.7 per cent to 6.7¢ at 12.50pm